Cytarabine ocfosfate – Interleukin Related interleukin-related.com

Product Name :
Cytarabine ocfosfate

Search keywords :
Cytarabine

drugId :
null

Target Vo:
DNA-directed DNA polymerase

Target Vo Short Name :
DNA-directed DNA polymerase

Moa_Name:
DNA-directed DNA polymerase inhibitors

First Approval Country :
Japan

First Approval Date Filter:
1992

Origin Company_Name :
Nippon Kayaku Co Ltd

Active Company_Name :
Nippon Kayaku Co Ltd

Active Indication_Name:
Leukemia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Hsp70 1A Antibody (YA727)
Ubiquitin D Antibody
S1PR4 Antibody: S1PR4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42 kDa, targeting to S1PR4. It can be used for WB, IHC-P assays with tag free, in the background of Rat.

Author: Interleukin Related

Related Posts